U2TH34 Stock Chart & Stats
R$131.00
R$0.00(0.00%)
―
--
Day’s Range― - ―
52-Week RangeR$40.00 - R$155.07
Previous CloseN/A
VolumeN/A
Average Volume (3M)0.00
Market Cap
R$111.54B
Enterprise ValueR$133.82K
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)17829.2
Beta0.07
Next Earnings
Aug 05, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding848,934,630
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
U2TH34 FAQ
What was United Therapeutics Corporation Unsponsored Brazilian Depositary Receipt Repr 0.05’s price range in the past 12 months?
United Therapeutics Corporation Unsponsored Brazilian Depositary Receipt Repr 0.05 lowest stock price was R$40.00 and its highest was R$155.07 in the past 12 months.
What is United Therapeutics Corporation Unsponsored Brazilian Depositary Receipt Repr 0.05’s market cap?
United Therapeutics Corporation Unsponsored Brazilian Depositary Receipt Repr 0.05’s market cap is R$111.54B.
When is United Therapeutics Corporation Unsponsored Brazilian Depositary Receipt Repr 0.05’s upcoming earnings report date?
United Therapeutics Corporation Unsponsored Brazilian Depositary Receipt Repr 0.05’s upcoming earnings report date is Aug 05, 2026 which is yesterday.
How were United Therapeutics Corporation Unsponsored Brazilian Depositary Receipt Repr 0.05’s earnings last quarter?
Currently, no data Available
Is United Therapeutics Corporation Unsponsored Brazilian Depositary Receipt Repr 0.05 overvalued?
According to Wall Street analysts United Therapeutics Corporation Unsponsored Brazilian Depositary Receipt Repr 0.05’s price is currently Undervalued.
Does United Therapeutics Corporation Unsponsored Brazilian Depositary Receipt Repr 0.05 pay dividends?
United Therapeutics Corporation Unsponsored Brazilian Depositary Receipt Repr 0.05 does not currently pay dividends.
What is United Therapeutics Corporation Unsponsored Brazilian Depositary Receipt Repr 0.05’s EPS estimate?
United Therapeutics Corporation Unsponsored Brazilian Depositary Receipt Repr 0.05’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does United Therapeutics Corporation Unsponsored Brazilian Depositary Receipt Repr 0.05 have?
United Therapeutics Corporation Unsponsored Brazilian Depositary Receipt Repr 0.05 has 848,934,630 shares outstanding.
What happened to United Therapeutics Corporation Unsponsored Brazilian Depositary Receipt Repr 0.05’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of United Therapeutics Corporation Unsponsored Brazilian Depositary Receipt Repr 0.05?
Currently, no hedge funds are holding shares in BR:U2TH34
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
United Therapeutics Corporation Unsponsored Brazilian Depositary Receipt Repr 0.05 (U2TH34) Earnings & Revenues
BioNTech SE ADR Unsponsored Brazilian Depositary Receipt Repr 0.0625 ADR
―
Incyte Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.5 Sh
―
Jazz Pharmaceuticals PLC Unsponsored BDR
―
Moderna, Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh
―
ResMed Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.25 Sh
―